top of page

Статьи:

​

2022 год

​

  • Artyushin O.I., Sharova E.V., Nikolaeva N.S., Aleksandrova Yu.R., Semakov A.V., Neganova M.E., Brel V.K. Modification of Sesquiterpene Lactones—Dehydrocostus Lactone and Alantolactone—by Click Chemistry Method. Cytotoxic Activity of the Obtained Conjugates // Russian Journal of General Chemistry, ISSN 1070-3632. - 2022. – V. 92. - No. 6. – pp. 960–968. DOI:10.1134/S107036322206007X

  • Nikolaeva N.S., Yandulova E.Yu., Aleksandrova Yu.R., Starikov A.S., Neganova M.E. The Role of a Pathological Interaction between β-amyloid and Mitochondria in the Occurrence and Development of Alzheimer’s Disease // Acta Naturae, ISSN 2075-8251. – 2022. – V. 14. – No. 3 (54). – pp. 19-34. DOI: 10.32607/actanaturae.11723

  • Neganova M.E., Aleksandrova Yu. R., Nikolaeva N. S., Brel V. K. Synthesis and biological testing of 3,5-bis(arylidene)-4-piperidone conjugates with 2,5-dihydro-5H-1,2-oxaphospholenes // Bioorganic & Medicinal Chemistry Letters. – 2022. T. 74. - P 128940. DOI: 10.1016/j.bmcl.2022.128940

  • Sukocheva O.A., Liu J., Beeraka N.M., Fan R., Neganova M.E., Aleksandrova Y.R., Grigorevskikh E.M., Chubarev V.N., Manogaran P. Perspectives of using microRNA-loaded nanocarriers for epigenetic reprogramming of drug resistant colorectal cancers // Seminars in Cancer Biology. – 2022. – V. 86(Pt 2). – pp. 358-375. DOI: 10.1016/j.semcancer.2022.05.012.

  • Neganova M.E., Aleksandrova Y.R., Sukocheva O.A., Klochkov S.G. Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders // Seminars in Cancer Biology. – 2022. – V. 86 (Pt 2). – pp. 805-833. DOI: 10.1016/j.semcancer.2022.06.011.

  • Neganova M.E., Klochkov S.G., Aleksandrova Yu. R., Aliev G. Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress. // Seminars in Cancer Biology. – 2022. – V. 83. – pp. 452-471. DOI: 10.1016/j.semcancer.2020.07.015.

  • Neganova, M.E.; Smirnova, E.V.; Sharova, E.V.; Artyushin, O.I.; Aleksandrova, Y.R.; Yandulova, E.Y.; Nikolaeva, N.S.; Brel, V.K. Design of Conjugates Based on Sesquiterpene Lactones with Polyalkoxybenzenes by “Click” Chemistry to Create Potential Anticancer Agents. Molecules 2022, 27, 8411. https:// doi.org/10.3390/molecules27238411 

  • Chugunova, E.; Matveeva, V.; Tulesinova, A.; Iskanderov, E.; Akylbekov, N.; Dobrynin, A.; Khаmatgalimov, A.; Appazov, N.; Boltayeva, L.; Duisembekov, B.; Zhanakov, M.; Aleksandrova, Y.; Sashenkova, T.; Klimanova, E.; Allayarova, U.; Balakina, A.; Mishchenko, D.; Burilov, A.; Neganova, M. Water-Soluble Salts Based on Benzofuroxan Derivatives—Synthesis and Biological Activity. Int. J. Mol. Sci. 2022, 23, 14902. https://doi.org/10.3390/ijms232314902 

  • Neganova M.E., Liu J., Aleksandrova Yu.R,. Vasilieva N., Semakov A., Yandulova E.Yu. et al. Development of Neuroprotective Agents for the Treatment of Alzheimer's Disease Using Conjugates of Serotonin with Sesquiterpene Lactones. Current Medicinal Chemistry. 2022. 10.2174/0929867330666221125105253

 

2021 год

​

  • Neganova, M.; Liu, J.; Aleksandrova, Y.; Klochkov, S.; Fan, R. Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment. Cancers 2021, 13, 6062. https://doi.org/10.3390/cancers13236062 Q1

  • Sukocheva O., Maksoud R., Beeraka N., Madhunapantula S-R., Sinelnikov M., Nikolenko V., Neganova M., Klochkov S., Kamal M-A., Marshall-Gradisnik S., Staines D, Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome, Journal of Advanced Research, 2021, doi.org/10.1016/j.jare.2021.11.013

  • Neganova, M.; Aleksandrova, Y.; Suslov, E.; Mozhaitsev, E.; Munkuev, A.; Tsypyshev, D.; Chicheva, M.; Rogachev, A.; Sukocheva, O.; Volcho, K.; Klochkov, S. Novel Multitarget Hydroxamic Acids with a Natural Origin CAP Group against Alzheimer’s Disease: Synthesis, Docking and Biological Evaluation. Pharmaceutics 2021, 13, 1893. https://doi.org/10.3390/pharmaceutics13111893 Q1

  • Balakina A., Prikhodchenko T., Amozova V., Stupina T., Mumyatova V., Neganova M., Yakushev I., Kornev A., Gadomsky S., Fedorov B., Mishchenko D. PREPARATION, ANTIOXIDANT PROPERTIES AND ABILITY TO INCREASE INTRACELLULAR NO OF A NEW PYRIDOXINE DERIVATIVE B6NO. Antioxidants. 2021. V. 10. № 9. P. 1451. https://doi.org/10.3390/antiox10091451 Q1

  • Zalevskaya O.A., Gureva Y.A., Kutchin A.V., Aleksandrova Yu.R., Yandulova E.Yu., Nikolaeva N.S., Neganova M.E. PALLADIUM COMPLEXES WITH TERPENE DERIVATIVES OF ETHYLENEDIAMINE AND BENZYLAMINE: SYNTHESIS AND STUDY OF ANTITUMOR PROPERTIES. Inorganica Chimica Acta. 2021. V. 527. P. 120593. https://doi.org/10.1016/j.ica.2021.120593

  • Vystorop I.V., Shilov G.V., Chernyak A.V., Klimanova E.N., Sashenkova T.E., Klochkov S.G., Neganova M.E., Aleksandrova Yu.R., Allayarova U.Yu., Mishchenko D.V. REGIOSELECTIVE SYNTHESIS, STRUCTURE, AND CHEMOSENSITIZING ANTITUMOR ACTIVITY OF CYCLIC HYDROXAMIC ACID BASED ON DL-VALINE. Russian Journal of Bioorganic Chemistry. 2021. V. 47. № 3. P. 757-764.

  • Pukhov S.A., Semakov A.V., Globa A.A., Anikina L.V., Afanasyeva S.V., Yandulova E.Y., Aleksandrova Yu.R., Neganova M.E., Klochkov S.G. NEW CONJUGATES OF DAUNORUBICIN WITH SESQUITERPENE LACTONES AND THEIR BIOLOGICAL ACTIVITY. ChemistrySelect. 2021. V. 6. № 32. P. 8446-8451.

  • Klochkov S.G., Neganova M.E. UNIQUE INDOLIZIDINE ALKALOID SECURININE IS A PROMISING SCAFFOLD FOR THE DEVELOPMENT OF NEUROPROTECTIVE AND ANTITUMOR DRUGS. RSC Advances. 2021. V. 11. № 31. P. 19185-19195.  https://doi.org/10.1039/D1RA02558A

  • Neganova M.E., Klochkov S.G., Aleksandrova Y.R., Pukhov S.A., Aliev G., Osipov V.N., Avdeev D.V., Gromyko A.V. NEW SPIROCYCLIC HYDROXAMIC ACIDS AS EFFECTIVE ANTIPROLIFERATIVE AGENTS. Anti-Cancer Agents in Medicinal Chemistry. 2021. V. 21. № 5. P. 597-610. DOI: 10.2174/1871520620666200527132420

  • Neganova M.E. Semakov A., Aleksandrova Yu.R., Yandulova E.Yu., Pukhov S.A., Anikina L.V., Klochkov S.G. N‐Alkylation of Anthracycline Antibiotics by Natural sesquiterpene Lactones as a Way to Obtain Antitumor Agents with Reduced Side Effects. Biomedicines. 2021. V. 9. P. 547.  https://doi.org/10.3390/biomedicines9050547  Q1

2020 год

​

  • Klochkov S.G., Neganova M.E., Pukhov S.A., Afanas′eva S.V., Aleksandrova Yu.R., Yandulova E.Yu. New Arteannuin B Derivatives and Their Cytotoxic Activity. Chem Nat Compd, 2020, 56, 445-451. doi: 10.1007/s10600-020-03059-2.

  • Neganova M.E., Klochkov S.G., Aleksandrova Yu.R., Osipov V.N., Avdeev D.V., Gromyko A.V., Pukhov S.A., Aliev G. New Spirocyclic Hydroxamic Acids as Effective Antiproliferative Agents. Anti-Cancer Agents in Medicinal Chemistry, 2020, 20 (1). doi: 10.2174/1871520620666200527132420.

  • Mikhaleva L.M., Davydov  A.I., Patsap  O.I., Mikhaylenko  E.V., Nikolenko  V.N., Neganova  M.E., Klochkov  S.G., Somasundaram  S.G., Kirkland  C.E., Aliev G. Malignant Transformation and Associated Biomarkers of Ovarian Endometriosis: A Narrative Review. Adv Ther, 2020, 37, 2580–2603. doi: doi.org/10.1007/s12325-020-01363-5.

  • Neganova M.E., Klochkov S.G., Pukhov S.A., Afanasieva S.V., Aleksandrova Yu.R., Yandulova E.Yu., Avila-Rodriguez M., Mikhaleva L.M., Nikolenko V.N., Somasundaram S.G., Kirkland C.E., Aliev G. Synthesis and Cytotoxic Activity of Azine Derivatives of 6- Hydroxyxanthanodiene. Current Cancer Drug Targets, 2020, 20 (1). doi: 10.2174/1568009620999200421200338.

  • Muresanu C., Somasundaram S.G., Neganova M.E., Bovina E.V., Vissarionov S.V., Ofodile O.N.F.C., Fisenko V.P., Bragin V., Minyaeva N.N., Chubarev V.N., Klochkov S.G., Tarasov V.V., Kirkland C.E., Aliev G. Updated Understanding of the Degenerative Disc Diseases - Causes versus Effects - Treatments, Studies and Hypothesis. Current Genomics, 2020, 21 (1). doi: 10.2174/1389202921999200407082315.

  • Brzecka A., Sarul K., Dyła T., Avila-Rodriguez M., Cabezas-Perez R., Chubarev V.N., Minyaeva N.N., Klochkov S.G., Neganova M.E., Mikhaleva L.M., Somasundaram S.G., Kirkland C.E., Tarasov V.V., Aliev G. The Association of Sleep Disorders, Obesity and Sleep-Related Hypoxia with Cancer. Current Genomics, 2020, 21 (1). doi: 10.2174/1389202921999200403151720.

  • Sukocheva O.A., Furuya H., Li Ng M., Friedemann M., Menschikowski M., Tarasov V.V., Chubarev V.N., Klochkov S.G., Neganova M.E., Mangoni A.A., Aliev G., Bishayee A. Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target. Pharmacology & Therapeutics, 207, 2020, 107464, doi: 10.1016/j.pharmthera.2019.107464.

  • Neganova M.E., Klochkov S.G., Aleksandrova Y.R., Aliev G. Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress. Semin Cancer Biol, 2020, S1044-579X(20)30176-0. doi: 10.1016/j.semcancer.2020.07.015.

  • Neganova M.E., Aleksandrova Y.R., Pukhov S.A., Klochkov S.G., Osipov V.N. Mechanisms of cytotoxic action of a series of directionally synthesized heterocyclic hydroxamic acids. Biomed Khim, 2020, 66 (4), 332-338. doi: 10.18097/PBMC20206604332.

  • Neganova M.E., Aleksandrova Yu.R., Nebogatikov V.O., Klochkov S.G., Ustyugov A.A. Promising molecular targets for pharmacological therapy of neurodegenerative pathologies. Acta Naturae, 2020, 12 (3(46)), 60-80. doi: 10.32607/actanaturae.10925.

  • Klochkov S.G., Neganova M.E., Aleksandrova Yu.R. Promising molecular targets for creation of antitumor drugs based on Ras proteins signaling cascades. Russian Journal of Bioorganic Chemistry, 2020, 46 (6), 580-592. doi: 10.31857/S0132342320050115.

  • Neganova ME, Klochkov SG, Aleksandrova YR, Aliev G. The Hydroxamic Acids as a Potential Anticancer and Neuroprotective Agents. Curr Med Chem. 2020 Dec 18. doi: 10.2174/0929867328666201218123154.

 

2019 год

​

  • Nikolenko V.N., Oganesyan M.V., Vovkogon A.D., Nikitina A.T., Sozonova E.A., Kudryashova V.A., Rizaeva N.A., Cabezas R., Avila-Rodriguez M., Neganova M.E., Mikhaleva L.M., Bachurin S.O., Somasundaram S.G., Kirkland C.E., Tarasov V.V., Aliev G. Current Understanding of Central Nervous System Drainage Systems: Implications in the Context of Neurodegenerative Diseases. Current Neuropharmacology, 2019, 17 (1). doi: 10.2174/1570159X17666191113103850.

  • Tarasov V.V., Svistunov A.A., Chubarev V.N., Zatsepilova T.A., Preferanskaya N.G., Stepanova O.I., Sokolov A.V., Dostdar S.A., Minyaeva N.N., Neganova M.E., Klochkov S.G., Mikhaleva L.M., Somasundaram S.G., Kirkland C.E., Aliev G. Feasibility of Targeting Glioblastoma Stem Cells: From Concept to Clinical Trials. Current Topics in Medicinal Chemistry, 2019, 19, 2974. doi: 10.2174/1568026619666191112140939.

  • Klochkov S.G., Pukhov S.A., Afanasieva S.V., Neganova M.E., Ananiev I.V., Avila-Rodriguez M., Tarasov V.V., Aliev G. A Novel Heterocyclic System Based on Natural Epoxyalantolactone. Frontiers in Chemistry, 2019, 7, 655. doi: 10.3389/fchem.2019.00655.

  • Klochkov S.G., Neganova M.E., Nikolenko V.N., Chen K., Somasundaram S.G., Kirkland C.E., Aliev G. Implications of nanotechnology for the treatment of cancer: Recent advances, Seminars in Cancer Biology, 2019, doi: 10.1016/j.semcancer.2019.08.028.

  • Tarasov V.V., Svistunov A.A., Chubarev V.N., Dostdar S.A., Sokolov A.V., Brzecka A., Sukocheva O., Neganova M.E., Klochkov S.G., Somasundaram S.G., Kirkland C.E., Aliev G. Extracellular vesicles in cancer nanomedicine, Seminars in Cancer Biology, 2019, doi: 10.1016/j.semcancer.2019.08.017.

  • Pukhov S.A., Afanas’eva S.V., Anikina L.V. et al. Cytotoxicity of Natural Alantolactones Conjugated to Substituted Piperazines. Chem Nat Compd 55, 41-46 (2019). doi: 10.1007/s10600-019-02611-z.

  • Klimanova E.N., Vistorop I.V., Sashenkova T.E., Mishchenko D.V., Neganova M.E. DL-valine cyclic hydroxamic acid: Synthesis and potential chemosensitizing antitumor action. AIP Conference Proceedings, 2019, 2063, 040025. doi: 10.1063/1.5087357.

  • Nikolaeva N.S., Maltsev A.V., Ovchinnikov R.K., Sokolov V.B., Aksinenko A.Y., Bovina E.V., Kinzirsky A.S. The study of cognitive-stimulating activity of fluorinated tetrahydrocarbazole derivatives and behavioral responses in transgenic TG6799 mice with Alzheimer’s disease. Biology Bulletin, 2019, 46 (3), 268-276.

  • Vasilieva N.A., Shevtsova E.F., Van’kin G.I., Lermontova N.N., Serkova T.P., Nikolaeva N.S., Bachurin S.O. Wave-like dose-dependence of the stimulating effects of dimebon on cognition in a wide dose range. Bulletin of Experimental Biology and Medicine, 2019, 167 (6), 740-743.

2018 год

​​

  • Shevtsova E.F., Vinogradova D.V., Neganova M.E., Shevtsov P.N., Lednev B.V., Bachurin S.O. Mitochondria are an important target in the search for new drugs for the treatment of alzheimer′s disease and senile dementia. Biomedical Chemistry: Research and Methods, 2018, 1 (3), e00058. doi: 10.18097/BMCRM00058.

  • Neganova M.E., Semenov V., Semenova M., Redkozubova O.M., Aleksandrova Yu.R., Lysova E.A., Klochkov S.G., Shevtsova E.F. Bioisosteric analogues of cinnamic acid as effective neuroprotectors. Biomedical Chemistry: Research and Methods, 2018, 1 (3), e00052. doi: 10.18097/BMCRM00052.

  • Dubrovskaya E.S., Semakov A.V., Afanasyeva S.V., Neganova M.E., Kozlovski V.I., Klochkov S.G. Protective effects of the natural sesquiterpene lactones against damage induced by glutamate and peroxide in SK-N-MC cells. Biomedical Chemistry: Research and Methods, 2018, 1 (3), e00051. doi: 10.18097/BMCRM00051.

  • Klochkov S.G., Pukhov S.A., Neganova M.E., Dubrovskaya E.S., Anikina L.A., Afanasyeva S.V., Semakov A.V. Biological activity of alantolactones in experiments on cells. Biomedical Chemistry: Research and Methods, 2018, 1 (3), e00047. doi:10.18097/BMCRM00047.

  • Milaeva E.R., Shpakovsky D.B., Maklakova I.A., Rufanov K.A., Neganova M.E., Shevtsova E.F., Churakov A.V., Babkova V.A., Babkov D.A., Kosolapov V.A., Spasov A.A. Novel diphenylsulfimide antioxidants containing 2,6-di-tert-butylphenol moieties. Russian Chemical Bulletin, 67 (11), 2025-2034. doi: 10.1007/s11172-018-2324-z.

 

2017 год

​

  • Milaeva E.R., Shpakovsky D.B., Dyadchenko V.P., Gryzlov A.I., Gracheva Y.A., Antonenko T.A., Parulava M.J., Albov D.V., Aslanov L.A., Shevtsova E.F., Dubova L.G., Shevtsov P.N., Neganova M.E. Synthesis and biological activity of novel Au (I) complexes with a protective antioxidant 2,6-di-tert-butylphenol group. Polyhedron, 2017, 127, 512-519. doi: 10.1016/j.poly.2016.08.037.

  • Makhaeva G.F., Sokolov V.B., Shevtsova E.F., Kovaleva N.V., Lushchekina S.V., Boltneva N.P., Rudakova E.V., Aksinenko A.Yu., Shevtsov P.N., Neganova M.E., Dubova L.G., Bachurin S.O. Focused design of polypharmacophoric neuroprotective compounds: Conjugates of gamma-carbolines with carbazole derivatives and tetrahydrocarbazole. Pure and Applied Chemistry, 2017, 89 (8), 1167-1184. doi: 10.1515/pac-2017-0308.

  • Neganova M.E., Klochkov S.G., Petrova L.N., Shevtsova E.F., Afanasieva S.V., Chudinova E.S., Fisenko V.P., Bachurin S.O., Barreto G.E., Aliev G. Securinine derivatives as potential anti-amyloid therapeutic approach. CNS & Neurological Disorders - Drug Targets, 2017, 16 (3), 351-355. doi: 10.2174/1871527315666161107090525.

  • Bachurin S.O., Shevtsova E.F., Makhaeva G.F., Grigoriev V.V., Boltneva N.P., Kovaleva N.V., Lushchekina S.V., Shevtsov P.N., Neganova M.E., Redkozubova O.M., Bovina E.V., Gabrelyan A.V., Sokolov V.B., Aksinenko A.Y., Aliev G., Fisenko V.P., Echeve. Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for ad treatment. Scientific Reports, 2017, 7, 45627. doi: 10.1038/srep45627.

  • Shevtsova E.F., Vinogradova D.V., Neganova M.E., Avila-Rodriguez M., Ashraf G.M., Barreto G.E., Bachurin S.O., Aliev G. Mitochondrial Permeability Transition Pore as a Suitable Target for Neuroprotective Agents Against Alzheimer's Disease. CNS & Neurological Disorders: Drug Targets, 2017, 16 (6), 677-685. doi: 10.2174/1871527316666170424114444.

  • Neganova M., Semenov V., Semenova M., Mischenko D., Redkozubova O., Klochkov S., Shevtsova E.. Modified cinnamic acid derivatives as effective mito- and neuroprotective substances. European neuropsychopharmacology, 2017, 27 (4), 657-658. doi: 10.1016/S0924-977X(17)31230-0.

  • Makarov M.V., Rybalkina E.Yu., Anikina L.V., Pukhov S.A., Klochkov S.G., Mischenko D.V., Neganova M.E., Khrustalev V.N., Klemenkova Z.S., Brel V.K.. 1,5-Diaryl-3-oxo-1,4-pentadienes based on (4-oxopiperidin-1-yl)(aryl)methyl phosphonate scaffold: synthesis and antitumor properties. Medicinal Chemistry Research, 2017, 26 (1), 140-152. doi: 10.1007/s00044-016-1726-4. 

  • Яндулова Е.Ю., Шевцова Е.Ф., Неганова М.Е. Изучение биологической активности вновь синтезированных производных изоксазолов и их биоизостерных аналогов с целью поиска соединений, обладающих антиоксидантными и нейропротекторными свойствами. Современные проблемы медицины и естественных наук, 2017, 271-274.

  • Ведесова Э.Л., Шевцова Е.Ф., Неганова М.Е. Изучение биологической активности новых химически модифицированных гидроксамовых кислот. Современные проблемы медицины и естественных наук, 2017, 274-277.

  • Nikolaeva N.S., Aksinenko A.Y., Kinzirsky A.S., Soldatova Y.V., Smolina A.V., Sokolov V.B., Kotelnikova R.A., Shtolko V.N., Kotelnikov A.I. Effect of fluorinated tetrahydrocarbazole derivatives on the enzymes of oxidative deamination of biogenic amines and on the process of lipid peroxidation. Russian Chemical Bulletin​, 2017 (5), 870-874.

​

2016 год

​​

  • Averina E.B., Vasilenko D.A., Gracheva Y.A., Grishin Y.K., Radchenko E.V., Burmistrov V.V., Butov G.M., Neganova M.E., Serkova T.P., Redkozubova O.M., Shevtsova E.F., Milaeva E.R., Kuznetsova T.S., Zefirov N.S. Synthesis and biological evaluation of novel 5-hydroxylaminoisoxazole derivatives as lipoxygenase inhibitors and metabolism enhancing agents. Bioorg. Med. Chem., 2016, 24 (4), 712-720. doi: 10.1016/j.bmc.2015.12.040.  

  • Neganova M.E., Proshin A.N., Redkozubova O.M., Serkov I.V., Serkova T.P., Dubova L.G., Shevtsova E.F. N,N’-Substituted Selenoureas as Polyfunctional Antioxidants. Bulletin of Experimental Biology and Medicine, 2016, 160 (3), 340-342. doi: 10.1007/s10517-016-3165-0.

  • Neganova M.E., Klochkov S.G., Afanasieva S.V., Serkova T.P., Chudinova E.S., Bachurin S.O., Reddy V.P., Aliev G., Shevtsova E.F. Neuroprotective Effects of the Securinine-Analogs: Identification of Allomargaritarine as a Lead Compound CNS & Neurological Disorders. Drug Targets, 2016, 15, 102-107. doi: 10.2174/1871527314666150821111812.

  • Neganova M., Averina E., Mischenko D., Serkova T., Redkozubova O., Shevtsova E. P.1.g.049 - Novel 5-hydroxylaminoisoxazole derivatives as effective antioxidants and metabolic enhancer agents. European Neuropsychopharmacology, 2016, 26 (2), 242. doi: dx.doi.org/10.1016/S0924-977X(16)31109-9.

  • Neganova M.E., Mishchenko D.V., Serkova T.P., Vystorop I.V., Shevtsova E.F. Biological activity of spirocyclic hydroxamic acids. Bulletin of experimental biology and medicine, 2016, 162 (8), 228-230. doi: 10.1007/s10517-016-3582-0.

​

2015 год

​

  • Milaeva E.R., Shpakovsky D.B., Gracheva Y.A., Antonenko T.A., Osolodkin D.I., Palyulin V.A., Shevtsov P.N., Neganova M.E., Vinogradova D.V., Shevtsova E.F.. Some insight into the mode of cytotoxic action of organotins with protective 2,6-di-tert-butylphenol group. Journal of Organometallic Chemistry, 2015, 782, 96-102. doi: 10.1016/j.jorganchem.2014.12.013.

  • Николаева Н.С., Соколов В.Б., Аксиненко А.Ю., Овчинников Р.К., Бачурин С.О., Кинзирский А.С. Психотропная активность новых фторсодержащих производных тетрагидрокарбазолов. Бюллетень экспериментальной биологии и медицины, 2015, 160 (10), 455-460.

​

2014 год

​

  • Klochkov S.G., Neganova M.E., Afanaseva S.V., Shevtsova E.F. Synthesis and antioxidant activity of securinine derivatives. Pharmaceutical Chemistry Journal, 2014, 48 (1), 15-17. doi: 10.1007/s11094-014-1035-5.

  • Neganova M.E., Klochkov S.G., Afanaseva S.V., Chudinova E.S., Serkova T.P., Shevtsova E.F.. Allomargaritarine as a basis for the creation of mitochondrial targeted potential neuroprotectors. European Neuropsychopharmacology, 2014, 24 (2), 261-262. doi: 10.1016/S0924-977X(14)70409-2.

  • Proshin A.N., Serkov I.V., Lermontov A.S., Shevtsova E.F., Neganova M.E., Bachurin S.O. Novel Bicyclic Derivatives of 1,3-Selenazine. Abstract:ChemInform, 2014, 45 (17), doi: 10.1002/chin.201417195.

  • Klochkov S.G., Neganova M.E., Afanaseva S.V., Shevtsova E.F. Synthesis and antioxidant activity of securinine derivatives. Pharmaceutical chemistry journal, 2014, 48 (1), 18-21. doi: 10.30906/0023-1134-2014-48-1-18-21.

  • Pukhov S.A., Neganova M.E., Anikina L.V., Shevtsova E.F., Afanaseva S.V., Klochkov S.G. Epoxyalantolactone and its derivaives inhibit the growth of mammary gland adenocarcinomas. Fundamental research, 2014, 9 (9), 1988-1992.

​

​

​

​

​

bottom of page